Taurus Asset Management LLC increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 188,200 shares of the medical device company's stock after buying an additional 6,500 shares during the period. Cooper Companies comprises approximately 1.7% of Taurus Asset Management LLC's portfolio, making the stock its 26th largest position. Taurus Asset Management LLC owned 0.09% of Cooper Companies worth $17,301,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Synovus Financial Corp increased its stake in shares of Cooper Companies by 1.6% in the fourth quarter. Synovus Financial Corp now owns 32,075 shares of the medical device company's stock valued at $2,949,000 after buying an additional 507 shares during the period. Sagespring Wealth Partners LLC acquired a new position in shares of Cooper Companies in the fourth quarter worth approximately $244,000. Townsquare Capital LLC boosted its holdings in Cooper Companies by 8.6% in the fourth quarter. Townsquare Capital LLC now owns 116,095 shares of the medical device company's stock valued at $10,673,000 after acquiring an additional 9,165 shares during the last quarter. Sterling Capital Management LLC increased its position in Cooper Companies by 32.8% during the 4th quarter. Sterling Capital Management LLC now owns 54,779 shares of the medical device company's stock valued at $5,036,000 after purchasing an additional 13,518 shares during the period. Finally, Covestor Ltd raised its holdings in Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares during the last quarter. 24.39% of the stock is owned by institutional investors.
Cooper Companies Stock Down 1.2 %
Shares of COO traded down $0.96 during trading hours on Tuesday, reaching $77.80. The stock had a trading volume of 1,386,329 shares, compared to its average volume of 1,399,687. The company has a market capitalization of $15.56 billion, a price-to-earnings ratio of 39.90, a P/E/G ratio of 2.25 and a beta of 1.01. The firm has a 50-day simple moving average of $83.93 and a 200 day simple moving average of $94.19. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 12 month low of $69.81 and a 12 month high of $112.38.
Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.
Analyst Ratings Changes
COO has been the topic of a number of analyst reports. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Robert W. Baird lowered their price objective on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research report on Friday, March 7th. Citigroup dropped their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Finally, JPMorgan Chase & Co. decreased their target price on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.
Check Out Our Latest Analysis on COO
Cooper Companies Company Profile
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Read More

Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.